These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30305806)

  • 21. Competing risks analysis with missing cause-of-failure-penalized likelihood estimation of cause-specific Cox models.
    Lô SN; Ma J; Manuguerra M; Moreno-Betancur M; Scolyer RA; Thompson JF
    Stat Methods Med Res; 2022 May; 31(5):978-994. PubMed ID: 35037794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constrained parametric model for simultaneous inference of two cumulative incidence functions.
    Shi H; Cheng Y; Jeong JH
    Biom J; 2013 Jan; 55(1):82-96. PubMed ID: 23090878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propensity-score matching with competing risks in survival analysis.
    Austin PC; Fine JP
    Stat Med; 2019 Feb; 38(5):751-777. PubMed ID: 30347461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confidence intervals for the cumulative incidence function via constrained NPMLE.
    Blanche P
    Lifetime Data Anal; 2020 Jan; 26(1):45-64. PubMed ID: 30539364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexible parametric joint modelling of longitudinal and survival data.
    Crowther MJ; Abrams KR; Lambert PC
    Stat Med; 2012 Dec; 31(30):4456-71. PubMed ID: 23037571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fine-Gray Model Under Interval Censored Competing Risks Data.
    Li C
    J Multivar Anal; 2016 Jan; 143():327-344. PubMed ID: 26543275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parametric likelihood inference for interval censored competing risks data.
    Hudgens MG; Li C; Fine JP
    Biometrics; 2014 Mar; 70(1):1-9. PubMed ID: 24400873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited.
    Putter H; Schumacher M; van Houwelingen HC
    Biom J; 2020 May; 62(3):790-807. PubMed ID: 32128860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models.
    Zhang X; Zhang MJ
    Comput Methods Programs Biomed; 2011 Jan; 101(1):87-93. PubMed ID: 20724020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative Incidence Association Models for Bivariate Competing Risks Data.
    Cheng Y; Fine JP
    J R Stat Soc Series B Stat Methodol; 2012 Mar; 74(2):183-202. PubMed ID: 22505835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Graft Failure and Patient Survival Modelling Based on Competing Risks Under Nonproportional Hazards.
    Valenta Z; Skrabaka D; Owczarek AJ; Kolonko A; Król R; Więcek A; Ziaja J
    Transplant Proc; 2022 May; 54(4):940-947. PubMed ID: 35450721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.
    Austin PC; Latouche A; Fine JP
    Stat Med; 2020 Jan; 39(2):103-113. PubMed ID: 31660633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive subdistribution hazards regression for competing risks data in case-cohort studies.
    Wogu AF; Li H; Zhao S; Nichols HB; Cai J
    Biometrics; 2023 Dec; 79(4):3010-3022. PubMed ID: 36606409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
    Lim HJ; Zhang X; Dyck R; Osgood N
    BMC Med Res Methodol; 2010 Oct; 10():97. PubMed ID: 20964855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for survival analysis in the presence of competing risks.
    Zhang Z; Geskus RB; Kattan MW; Zhang H; Liu T
    Ann Transl Med; 2017 Oct; 5(20):403. PubMed ID: 29152503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communicating and understanding statistical measures when quantifying the between-group difference in competing risks.
    Wu H; Zhang C; Hou Y; Chen Z
    Int J Epidemiol; 2023 Dec; 52(6):1975-1983. PubMed ID: 37738672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cause-specific hazard regression estimation for modified Weibull distribution under a class of non-informative priors.
    Rehman H; Chandra N; Hosseini-Baharanchi FS; Baghestani AR; Pourhoseingholi MA
    J Appl Stat; 2022; 49(7):1784-1801. PubMed ID: 35707558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.